Marksans Pharma Ltd. Conference Calls and Earnings Call Transcripts

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform the stock exchanges that the Company has uploaded the audio recording of investor(s) / analyst(s) meet for Q4FY25 financial performance and strategy update held today i.e. May 20, 2025 on the Company's website at http://marksanspharma.com/investors-meet.html

pdf

Marksans Pharma Ltd.

20 May 2025

164.76

-1.35%

Marksans Pharma Results Earnings Call for Q4FY25 & Full Year

Conference Call with Marksans Pharma Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Marksans Pharma Ltd.

25 Feb 2025

164.76

-1.35%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Kindly find enclosed

pdf

Marksans Pharma Ltd.

25 Feb 2025

164.76

-1.35%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Kindly find enclosed

pdf

Marksans Pharma Ltd.

12 Feb 2025

164.76

-1.35%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Kindly find enclosed intimation for uploading of audio recording of Investor(s) / analyst(s) meet - Q3FY2024-25 Financial Results Conference Call

pdf

Marksans Pharma Ltd.

12 Feb 2025

164.76

-1.35%

Marksans Pharma Results Earnings Call for Q3FY25

Conference Call with Marksans Pharma Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Marksans Pharma Ltd. Conference Calls and Earnings Call Transcripts